tiprankstipranks
Trending News
More News >
Linical Co., Ltd. (JP:2183)
:2183
Japanese Market

Linical Co., Ltd. (2183) Price & Analysis

Compare
0 Followers

2183 Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

<0.01%100.00%
Insiders
<0.01%
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors

2183 FAQ

What was Linical Co., Ltd.’s price range in the past 12 months?
Linical Co., Ltd. lowest stock price was ¥258.00 and its highest was ¥463.00 in the past 12 months.
    What is Linical Co., Ltd.’s market cap?
    Linical Co., Ltd.’s market cap is ¥7.45B.
      When is Linical Co., Ltd.’s upcoming earnings report date?
      Linical Co., Ltd.’s upcoming earnings report date is Aug 13, 2025 which is in 39 days.
        How were Linical Co., Ltd.’s earnings last quarter?
        Linical Co., Ltd. released its earnings results on May 15, 2025. The company reported -¥9.84 earnings per share for the quarter, missing the consensus estimate of N/A by -¥9.84.
          Is Linical Co., Ltd. overvalued?
          According to Wall Street analysts Linical Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Linical Co., Ltd. pay dividends?
            Linical Co., Ltd. pays a Annually dividend of ¥16 which represents an annual dividend yield of 4.85%. See more information on Linical Co., Ltd. dividends here
              What is Linical Co., Ltd.’s EPS estimate?
              Linical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Linical Co., Ltd. have?
              Linical Co., Ltd. has 24,740,000 shares outstanding.
                What happened to Linical Co., Ltd.’s price movement after its last earnings report?
                Linical Co., Ltd. reported an EPS of -¥9.84 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.334%.
                  Which hedge fund is a major shareholder of Linical Co., Ltd.?
                  Currently, no hedge funds are holding shares in JP:2183

                  Company Description

                  Linical Co., Ltd.

                  Linical Co., Ltd. is a global contract research organization (CRO) that specializes in providing comprehensive clinical trial services to pharmaceutical, biotechnology, and medical device companies. The company is headquartered in Japan and operates across various regions, including Asia, Europe, and North America. Linical offers a wide range of services, including clinical development, post-marketing surveillance, and data management, focusing on therapeutic areas such as oncology, neurology, and immunology.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Cytori Cell Research Institute, Inc.
                  Kidswell Bio Corporation
                  Noile-Immune Biotech Inc.
                  OncoTherapy Science
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis